Earnings season. Novo Nordisk, AbbVie, Exxon Mobil, Chevron, Honeywell, Total, Altria, LafargeHolcim, Colgate-Palmolive, Safran, Itochu, Cellnex, Glencore, Swiss Re and NatWest are among companies reporting their results today.

A few results:

  • Alphabet’s share price rose sharply following the publication of higher than expected results.
  • Amazon.com: In the fourth quarter, the e-tailer should post record results, after an already very strong third quarter, thanks in particular to AWS.
  • Apple: the stock is losing more than 4% off session. If results have exceeded expectations, iPhone sales are a little disappointing.
  • Facebook: the stock lost ground after the close in the wake of good results but cautious comments on 2021.
  • LafargeHolcim: the cement manufacturer reported better than expected quarterly results, both in terms of sales and operating income. It was relatively confident for the rest of the year.
  • NatWest: results are slightly higher than expected, and annual provisions will be in the low range of what was previously announced.
  • Starbucks: Share price fell on mixed outlook
  • Total: The oil major suffered a 72% contraction in net profit in the third quarter, but the quarterly dividend of EUR 0.66 per share is maintained. Total has revised downwards its 2020 investment forecasts.
  • Twitter: the stock drops 17% after the session after the announcement of a weaker-than-expected quarterly number of users.

In other news:

  • Continental's CEO must resign for health reasons.
  • AB Volvo will sell its UD division (formerly Nissan Diesel) to Isuzu as part of a joint venture for SEK 20 billion.
  • Netflix rose 3% yesterday after announcing a price increase in the US.
  • BP Plc will close Australia's largest refinery to convert it into an import terminal.
  • LG Chem shareholders approved the principle of a spin-off of the battery business.
  • Exxon Mobil will cut 14,000 jobs worldwide, or about 15% of its workforce, to cope with the new oil situation.
  • Takeda signs a distribution contract for Moderna's future Covid-19 vaccine in Japan, with the support of authorities.
  • AMP Limited was approached by Ares Management for an acquisition.
  • Prosus will repurchase $5 billion of Naspers and Prosus shares.
  • Roche obtains a new green light from the FDA for its Cobas test.
  • Partners Group and UBS Group join forces in wealth management products.